2014•PubMedRequires access
Effects of nebivolol on liver fibrosis induced by bile duct ligation in Wistar rats.
Catarina Teixeira, Elisabete Franco, Paula A. Oliveira, Bruno Colaço, Adelina Gama, João Soares Carrola, Carlos André Miranda Pires, Aura Antunes Colaço, Maria João Pires
Open publisher page 6 citations
Abstract
AIM: To study the effect of nebivolol on liver fibrosis induced by common bile duct ligation (BDL) in rats. MATERIALS AND METHODS: After BDL, Wistar rats were divided into three groups (n=24): SO, sham-operated animals; BDL, BDL rats without treatment; BDL+N, BDL rats treated with nebivolol for five weeks. Alanine aminotransferase, aspartate aminotransferase, gamma glutamyltransferase, total bilirubin and albumin levels were assessed. Liver samples collected were stained with hematoxylin-eosin, Masson's trichrom and reticulin. RESULTS: Mortality reached 37.5% in the BDL group, whereas no deaths were observed in the SO and BDL+N groups. The BDL group showed hepatic damage as evidenced by elevation in serum biochemical parameters and fibrosis scores. These pathophysiological changes were attenuated in the BDL+N group. However, there was no significant difference between these two groups. CONCLUSION: Nebivolol improved the survival rate of animals with BDL, but was unable to significantly improve liver function or reduce liver fibrosis.